Skip to content

Urgent urology symptoms What to do

Combining Talazoparib and Enzalutamide for Prostate Cancer Care

David Cohen, M.DPublished November 18, 20268 min read
Combining Talazoparib and Enzalutamide for Prostate Cancer Care

Key points

  • Talazoparib and enzalutamide are medications used in treating prostate cancer.
  • Prostate cancer develops when cells in the prostate gland grow uncontrollably.
  • The combination of talazoparib and enzalutamide is being studied because each drug targets prostate cancer in a different way.
  • Like all medications, talazoparib and enzalutamide can cause side effects.

What Is Talazoparib and Enzalutamide?

Talazoparib and enzalutamide are medications used in treating prostate cancer. Talazoparib is a type of drug known as a PARP inhibitor. It works by preventing cancer cells from repairing themselves, which can slow or stop their growth. Enzalutamide, on the other hand, is an androgen receptor inhibitor. It blocks the effects of androgens, which are male hormones that can promote the growth of prostate cancer cells.

A recent report from Clinical Oncology News highlights the combination of talazoparib and enzalutamide for treating metastatic prostate cancer. Metastatic means that the cancer has spread beyond the prostate to other parts of the body. This combination therapy is being explored to see if it can improve outcomes for patients with advanced prostate cancer. Early research suggests this approach might offer new hope, but more studies are needed to confirm its effectiveness and safety.

Both drugs have been used individually in prostate cancer treatment. However, the potential benefits of combining them could be significant. By targeting cancer cells in two different ways, the treatment may be more effective than using either drug alone. Patients should discuss with their doctors whether this combination therapy might be an option for them, considering their specific medical situation.

How Does Prostate Cancer Develop?

Prostate cancer develops when cells in the prostate gland grow uncontrollably. The prostate is a small gland in men that produces seminal fluid. Most prostate cancers are adenocarcinomas, which means they develop from the gland cells. The exact cause of prostate cancer is not known, but several factors can increase a man's risk of developing the disease.

Age is a significant risk factor. Prostate cancer is rare in men under 40, but the risk increases as a man gets older. Family history also plays a role. Men with a father or brother who had prostate cancer are more likely to develop it themselves. Race is another factor, with African American men at higher risk than men of other races. Diet and lifestyle may also contribute, although the links are less clear.

Early prostate cancer often has no symptoms. As it progresses, symptoms might include trouble urinating, decreased force in the urine stream, blood in urine or semen, swelling in the legs, or discomfort in the pelvic area. However, these symptoms can also be caused by other conditions, making regular check-ups important for early detection.

Why Combine Talazoparib and Enzalutamide?

The combination of talazoparib and enzalutamide is being studied because each drug targets prostate cancer in a different way. By using both, doctors hope to attack the cancer more effectively. Talazoparib's role as a PARP inhibitor makes it especially useful in cancers with certain genetic mutations like BRCA1 and BRCA2, which affect the cancer cells' ability to repair DNA.

Enzalutamide's role is to block androgen receptors, which are like switches that turn on genes that help cancer grow. By blocking these receptors, enzalutamide can slow down or stop the growth of cancer cells that rely on androgens. Combining it with talazoparib might enhance the overall effect on slowing cancer growth.

Early research into this combination is promising, but it is still new. Clinical trials are currently underway to better understand how effective and safe this combination is. Patients interested in new treatments should consult their healthcare providers to learn about clinical trials they might be eligible for, and to discuss whether this combination is appropriate for their situation.

What Are the Potential Side Effects?

Like all medications, talazoparib and enzalutamide can cause side effects. It is crucial for patients to be aware of these and to communicate any issues to their healthcare team. Talazoparib can cause side effects such as nausea, fatigue, anemia, and low blood cell counts. These side effects occur because the drug affects not just cancer cells, but also some healthy cells in the body.

Enzalutamide can cause fatigue, hot flashes, weakness, and high blood pressure. Some patients might experience more serious side effects, such as seizures or heart problems, though these are less common. It's important to monitor for any unusual symptoms and report them to a healthcare provider immediately.

When drugs are combined, there can be an increased risk of side effects. Patients undergoing combination therapy need regular monitoring to manage any adverse effects. This ensures that the benefits of the treatment outweigh the risks. Doctors may adjust doses or suggest supportive treatments to help manage side effects.

When Should Someone See a Doctor?

Seeing a doctor regularly is important for anyone with prostate cancer, whether they're on a new treatment like the combination of talazoparib and enzalutamide or not. However, certain symptoms should prompt immediate medical attention. If a patient experiences severe side effects from medication, such as difficulty breathing, chest pain, or sudden weakness, they should seek urgent care.

Other warning signs that require a doctor's attention include being unable to urinate, severe pain in the side or back, and the presence of a lot of blood or clots in the urine. Additionally, a sudden severe pain or swelling in a testicle, or a fever with chills during a urinary infection, should be evaluated promptly.

Regular follow-ups are necessary to track the progress of the treatment and to make any necessary adjustments. Patients should maintain open communication with their healthcare team and report any new or worsening symptoms. This proactive approach helps manage the condition effectively and improves overall outcomes.

How Is the Combination Therapy Administered?

The administration of talazoparib and enzalutamide combination therapy involves taking each medication as prescribed by a healthcare provider. Talazoparib is usually taken orally, in the form of a capsule, once a day. Enzalutamide is also taken orally, typically in the form of a capsule or tablet, once a day.

Patients should follow the dosing instructions carefully and report any difficulties in sticking to the regimen. This might include side effects, trouble swallowing pills, or any other challenges. Consistency in taking medication is crucial to the effectiveness of the treatment.

Doctors often provide detailed instructions on how to take each medication, including whether to take them with food or on an empty stomach. It's important for patients to understand these instructions and to ask questions if anything is unclear. Regular blood tests and check-ups are part of the process to ensure the treatment is working as intended and to adjust as needed.

What Are the Next Steps for Patients?

Patients interested in combination therapy with talazoparib and enzalutamide should first have a detailed discussion with their healthcare provider. This conversation can help determine if they are a suitable candidate based on their medical history and current health status. It is also the time to discuss potential benefits, risks, and side effects.

For those eligible, participating in clinical trials can be an option. Clinical trials provide access to new treatments and contribute to research that may benefit future patients. Patients should ask their doctors about available trials and what participation would entail.

Ultimately, the decision to pursue this treatment should be made with a thorough understanding of the potential outcomes and a strong support system in place. Family, friends, and healthcare teams can provide the necessary support to navigate the treatment process. Patients should remain informed and proactive about their health to make the best decisions for themselves.

Want to learn more? Read our guide to how the urinary system works and our overview of kidney stones.

Source: Talazoparib Plus Enzalutamide for Metastatic Prostate Cancer (Clinical Oncology News)

This article is for general information only and is not medical advice. Always talk with your doctor about your symptoms and treatment. If you cannot pass urine, have severe pain with fever, or have sudden testicle pain, call 911 or go to the nearest emergency room.

Frequently asked questions

What is the purpose of combining Talazoparib and Enzalutamide for prostate cancer?

Combining Talazoparib and Enzalutamide aims to enhance treatment effectiveness for prostate cancer. This combination targets cancer cells more aggressively. It may offer a new option for patients with specific cancer characteristics.

How do Talazoparib and Enzalutamide work together in treating prostate cancer?

Talazoparib is a PARP inhibitor that interferes with cancer cell repair, while Enzalutamide blocks androgen receptors. Together, they disrupt cancer cell growth and survival. This dual approach can slow disease progression.

Who might benefit from the combination of Talazoparib and Enzalutamide?

Patients with metastatic castration-resistant prostate cancer may benefit from this combination. Those with specific genetic mutations might see more effectiveness. Consult a healthcare provider to determine if it's a suitable option.

Are there known side effects of using Talazoparib and Enzalutamide together?

Yes, both medications have known side effects. Common ones may include fatigue, nausea, and blood cell changes. Discuss potential side effects with your healthcare provider before starting treatment.

How is the treatment with Talazoparib and Enzalutamide administered?

Both medications are typically taken orally as pills. The exact dosage and schedule depend on individual treatment plans. Always follow your healthcare provider's instructions regarding administration.

Can this combination therapy cure prostate cancer?

Currently, there is no cure for prostate cancer, but this combination may help manage the disease. It can slow progression and improve quality of life. Always discuss treatment goals with your healthcare provider.

What should patients discuss with their doctors before starting this treatment?

Patients should discuss their overall health, other medications, and any pre-existing conditions. It's important to understand the potential benefits and risks. A healthcare provider can help determine if this treatment is appropriate.

Are there any lifestyle changes recommended while on this treatment?

Maintaining a healthy lifestyle can support treatment effectiveness. This includes a balanced diet, regular exercise, and avoiding tobacco and excessive alcohol. Your healthcare provider may offer specific recommendations.

How long might a patient need to be on this combination treatment?

The duration of treatment varies based on individual response and cancer progression. Regular monitoring and consultations with a healthcare provider will guide the treatment timeline. It's important to adhere to scheduled check-ups.

Is this combination therapy approved by health authorities?

As of the latest updates, clinical trials continue to explore this combination's potential benefits. Regulatory approvals depend on ongoing research and outcomes. Always consult your healthcare provider for the most current information.

What should patients expect in terms of monitoring and follow-up care?

Patients will undergo regular monitoring to assess treatment effectiveness and side effects. This includes routine blood tests and imaging studies. Consistent follow-up care ensures timely adjustments to the treatment plan.

When should someone see a doctor regarding this treatment option?

See a doctor if you experience new or worsening symptoms while on this treatment. Urgent symptoms like inability to urinate, severe pain with fever, or sudden testicle pain require immediate attention. Call 911 or go to the emergency room for these urgent issues.

The content on this site is for information only and is not a substitute for professional medical advice, diagnosis or treatment. If you cannot pass urine, have a fever with back or side pain, or sudden severe pain in the testicle, call 911 or go to an emergency department.

Urinary symptoms?

Weak stream, urgency, up at night? Score it in two minutes.

Seven questions from the International Prostate Symptom Score show whether symptoms are mild, moderate or severe, and when to see a doctor.

Take the symptom score

When to get help

Most urology problems can wait for an appointment. These can’t.

Call 911 or go to an emergency department if you have any of these:

  • You cannot pass urine at allAcute urinary retention: a painful, swollen bladder. It needs a catheter, often within hours.
  • Fever or chills with back or side painA blocked, infected kidney (for example behind a stone) can turn into sepsis quickly.
  • Sudden, severe pain in a testiclePossible testicular torsion. The testicle can often be saved only within about 6 hours.
  • An erection lasting over 4 hoursPriapism. Without treatment it can cause permanent damage.
Call 911

Outside the US, call your local emergency number.

See a doctor within days

  1. 01Blood in your urineEven once, and even without pain. Usually harmless, but it is the most common first sign of bladder and kidney cancer.
  2. 02Burning, frequent or cloudy urineTypical of a urinary tract infection, which usually clears with treatment.
  3. 03A lump or swelling in a testicleMost lumps are benign; testicular cancer is very treatable when found early.

General guidance only. If you are unsure how urgent a symptom is, call your doctor or a nurse advice line.